Ben Venue Laboratories, Inc. to cease production

Ben Venue Laboratories, Inc. of Bedford, Ohio, a subsidiary of Boehringer Ingelheim Corp., has decided to cease production by the end of 2013. Despite the ongoing support of the U.S. Food and Drug Administration (FDA), the tremendous dedication of employees, and significant investments in facility upgrades, the company cannot return to sustainable production.

See more information under:

http:www.benvenue.com/news_/press_releases/october_3_2013.html